Phase 4
N=12
Determination of the Duration of Action of a Lidocaine and a Bupivacaine Digital Nerve Block in Human Volunteers
Onset and Duration of a Digital Nerve Block
Bottom Line
View on ClinicalTrials.gov: NCT01508832 ↗Enrolled (actual)
12
Serious AEs
0.0%
Results posted
Aug 2013
Primary outcome: Primary: The Change in the Average Finger Temperature From Baseline to Post-intervention. — -1.35; 0.93 degrees centigrade
Study Design & Population
- Study type
- Interventional
- Phase
- Phase 4
- Interventions
- Lidocaine Digital Nerve Block (Drug); Bupivacaine Digital Block (Drug)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- University of California, San Francisco
- Primary completion
- Mar 2013
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY The Change in the Average Finger Temperature From Baseline to Post-intervention. |
-1.35; 0.93 | — |
Summary
The duration of the autonomic (sympathetic) block will last longer than the sensory block. The duration of the increased perfusion index will last longer than either the sympathetic or sensory block.
Eligibility Criteria
Inclusion Criteria
- Non-smokers
Exclusion Criteria
- History of allergic response to local anesthetics
- BMI >25
- Pregnant of nursing
- Current smokers or past smokers of > 1 pack year history
- Neurological deficit and/or injury in the upper extremities
- Current respiratory infection
- Per investigator judgement, would not be suitable for study
Data sourced from ClinicalTrials.gov (NCT01508832). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.